Juan Carlos Tinoco

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Ana Strezova, Javier Díez‐Domingo, Kamal Al Shawafi et al. · Open Forum Infectious Diseases · 2022 · 98 citations · Full text

Immunodeficiencies, Immunology, Vaccine Surveillance +17

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 90 citations · Full text

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

Juan Carlos Tinoco, Noris Pavía-Ruz, Aurelio Cruz-Valdéz et al. · Vaccine · 2014 · 78 citations · Full text

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois et al. · Vaccine · 2019 · 61 citations · Full text